Chlamydia pneumoniae infection of vascular smooth muscle and endothelial cells activates NF-κB and induces tissue factor and PAI-1 expression -: A potential link to accelerated arteriosclerosis

被引:198
作者
Dechend, R
Maass, M
Gieffers, J
Dietz, R
Scheidereit, C
Leutz, A
Gulba, DC
机构
[1] Max Delbruck Ctr Mol Med, D-13122 Berlin, Germany
[2] Univ Lubeck, D-2400 Lubeck, Germany
[3] Inst Med Microbiol & Hyg, Lubeck, Germany
[4] Humboldt Univ, Berlin, Germany
[5] Franz Volhard Clin, Berlin, Germany
关键词
plasminogen activator inhibitor 1; tissue factor; interleukins; arteriosclerosis; C; pneumoniae;
D O I
10.1161/01.CIR.100.13.1369
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background-Recent reports link C. pneumoniae infection of arteriosclerotic lesions to the precipitation of acute coronary syndromes, which also feature tissue factor and plasminogen activator inhibitor 1 (PAI-1) overexpression. We investigated whether or not C. pneumoniae can induce thrombogenicity by upregulation of procoagulant proteins. Methods and Results-Human vascular endothelial and smooth muscle cells were infected with a strain of C. pneumoniae isolated from an arteriosclerotic coronary artery. Tissue factor, PAI-1: and interleukin-6 expression was increased in infected cells. Concomitantly, NF-kappa B was activated and I kappa B alpha degraded. p50/p65 heterodimers were identified as the components responsible for the NF-kappa B activity. Conclusions-These data provide evidence that C. pneumoniae infection can induce procoagulant protein and proinflammatory cytokine expression. This cellular response is accompanied by activation of NF-kappa B. Our results demonstrate how C. pneumoniae infection may initiate acute coronary syndromes.
引用
收藏
页码:1369 / 1373
页数:5
相关论文
共 23 条
[1]   Mechanisms of disease - Nuclear factor-kappa b - A pivotal transcription factor in chronic inflammatory diseases [J].
Barnes, PJ ;
Larin, M .
NEW ENGLAND JOURNAL OF MEDICINE, 1997, 336 (15) :1066-1071
[2]   Detection of Chlamydia pneumoniae but not cytomegalovirus in occluded saphenous vein coronary artery bypass grafts [J].
Bartels, C ;
Maass, M ;
Bein, G ;
Malisius, R ;
Brill, N ;
Bechtel, JFM ;
Sayk, F ;
Feller, AC ;
Sievers, HH .
CIRCULATION, 1999, 99 (07) :879-882
[3]   Activated transcription factor nuclear factor-kappa B is present in the atherosclerotic lesion [J].
Brand, K ;
Page, S ;
Rogler, G ;
Bartsch, A ;
Brandl, R ;
Knuechel, R ;
Page, M ;
Kaltschmidt, C ;
Baeuerle, PA ;
Neumeier, D .
JOURNAL OF CLINICAL INVESTIGATION, 1996, 97 (07) :1715-1722
[4]   Coronary risk factors and plaque morphology in men with coronary disease who died suddenly [J].
Burke, AP ;
Farb, A ;
Malcom, GT ;
Liang, YH ;
Smialek, J ;
Virmani, R .
NEW ENGLAND JOURNAL OF MEDICINE, 1997, 336 (18) :1276-1282
[5]   Chlamydia in coronary plaques - Hidden culprit or harmless hobo? [J].
Capron, L .
NATURE MEDICINE, 1996, 2 (08) :856-857
[6]   NF-κB-dependent inhibition of apoptosis is essential for host cell survival during Rickettsia rickettsii infection [J].
Clifton, DR ;
Goss, RA ;
Sahni, SK ;
van Antwerp, D ;
Baggs, RB ;
Marder, VJ ;
Silverman, DJ ;
Sporn, LA .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1998, 95 (08) :4646-4651
[7]  
DAWSON SJ, 1993, J BIOL CHEM, V268, P10739
[8]   The Bcl-3 oncoprotein acts as a bridging factor between NF-κB/Rel and nuclear co-regulators [J].
Dechend, R ;
Hirano, F ;
Lehmann, K ;
Heissmeyer, V ;
Ansieau, S ;
Wulczyn, FG ;
Scheidereit, C ;
Leutz, A .
ONCOGENE, 1999, 18 (22) :3316-3323
[9]   INHIBITION OF NF-KAPPA-B BY PYRROLIDINE DITHIOCARBAMATE BLOCKS ENDOTHELIAL-CELL ACTIVATION [J].
FERRAN, C ;
MILLAN, MT ;
CSIZMADIA, V ;
COOPER, JT ;
BROSTJAN, C ;
BACH, FH ;
WINKLER, H .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1995, 214 (01) :212-223
[10]  
Fryer RH, 1997, J INVEST MED, V45, P168